Carcinoma, Non-Small-Cell Lung: all 6,645 studies

Page 28 of 67. Open to participants first (1,667), then studies with results posted, then the rest; newest registration first within each.

• A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung CancerCompletedNCT00723957Phase 2Results posted
• A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.CompletedNCT00718315Phase 3Results posted
• LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or GefitinibCompletedNCT00711594Phase 2Results posted
• A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung CancerCompletedNCT00701558Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.CompletedNCT00700180Phase 2Results posted
• Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00698815Phase 2Results posted
• Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior TherapyTerminatedNCT00694603Phase 2Results posted
• Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination ChemotherapyCompletedNCT00693992Phase 3Results posted
• Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung CancerCompletedNCT00687297Phase 2Results posted
• Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerCompletedNCT00686959Phase 3Results posted
• Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or MelanomaTerminatedNCT00685750Not applicableResults posted
• Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung CancerCompletedNCT00683904Phase 1Results posted
• Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)CompletedNCT00673738Phase 2Results posted
• Trial Of CP-751, 871 And Erlotinib In Refractory Lung CancerTerminatedNCT00673049Phase 3Results posted
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00664105Phase 2Results posted
• Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By SurgeryTerminatedNCT00662311Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung CancerCompletedNCT00661778Phase 2Results posted
• S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00661193Phase 2Results posted
• Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00660816Phase 2Results posted
• BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)CompletedNCT00656136Phase 3Results posted
• Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00655850Phase 2Results posted
• A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007)CompletedNCT00654420Phase 2Results posted
• Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung CancerCompletedNCT00654030Phase 2Results posted
• A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung CancerCompletedNCT00653939Phase 2Results posted
• APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerCompletedNCT00652340Phase 2Results posted
• Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLCCompletedNCT00647426Phase 2Results posted
• Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00642759Phase 2Results posted
• A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated RashCompletedNCT00642473Phase 2Results posted
• AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination ChemotherapyCompletedNCT00638937Phase 2Results posted
• Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)TerminatedNCT00632203Phase 2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaTerminatedNCT00617656Phase 3Results posted
• Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung CancerCompletedNCT00614822Phase 2Results posted
• Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on ErlotinibCompletedNCT00609804Phase 2Results posted
• A Study for Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT00609518Phase 2Results posted
• SELINE: Second-Line Iressa Phase IV Study in NSCLC PatientsCompletedNCT00608868Phase 4Results posted
• Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentCompletedNCT00606502Phase 2Results posted
• A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00606021Phase 2Results posted
• Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung CancerCompletedNCT00603538Phase 1Results posted
• Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00602797Phase 2Results posted
• Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLCCompletedNCT00602030Phase 1/2Results posted
• Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the PleuraTerminatedNCT00601848Phase 2Results posted
• A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.CompletedNCT00600821Phase 2Results posted
• Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00600015Phase 2Results posted
• Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)CompletedNCT00599755Phase 1Results posted
• Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyTerminatedNCT00596830Phase 3Results posted
• A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00596648Phase 1/2Results posted
• Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00592007Phase 2Results posted
• A Phase I/II Trial of Stereotactic Body Radiation TherapyCompletedNCT00591838Phase 1/2Results posted
• Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung CancerCompletedNCT00590902Phase 2Results posted
• Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00589056Phase 1/2Results posted
• Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor GeneCompletedNCT00588445Phase 2Results posted
• A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced CancerCompletedNCT00585195Phase 1Results posted
• Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFRCompletedNCT00567359Phase 2Results posted
• Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung CancerTerminatedNCT00564876Phase 2Results posted
• FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerCompletedNCT00564733Phase 2Results posted
• TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00563784Phase 2Results posted
• Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00560573Phase 1Results posted
• Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00559897Phase 2Results posted
• A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00558636Phase 3Results posted
• A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556712Phase 3Results posted
• A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00556322Phase 3Results posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00553462Phase 2Results posted
• Trial Of PF-00299804 In Patients With Advanced Refractory Lung CancerCompletedNCT00553254Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By SurgeryCompletedNCT00551369Phase 2Results posted
• Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00550537Phase 2Results posted
• A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerCompletedNCT00550173Phase 2Results posted
• Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung CancerTerminatedNCT00549328Phase 2Results posted
• PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And ErlotinibCompletedNCT00548093Phase 2Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung CancerTerminatedNCT00545948Phase 2Results posted
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00541099Phase 2Results posted
• Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionCompletedNCT00540982Phase 1/2Results posted
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00540514Phase 3Results posted
• Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00536107Phase 4Results posted
• Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line ChemotherapyTerminatedNCT00534209Phase 1/2Results posted
• High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00533949Phase 3Results posted
• Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With ChemotherapyCompletedNCT00533429Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00531960Phase 2Results posted
• A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.CompletedNCT00531934Phase 2Results posted
• Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung CancerTerminatedNCT00530634Phase 2Results posted
• Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerCompletedNCT00530621Phase 2Results posted
• Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung CancerCompletedNCT00529100Phase 1/2Results posted
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)CompletedNCT00527735Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating MutationsCompletedNCT00525148Phase 2Results posted
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTerminatedNCT00520845Phase 2Results posted
• Chemotherapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00520676Phase 3Results posted
• A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.CompletedNCT00518011Phase 2Results posted
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLCCompletedNCT00517595Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted
• Single Agent Alimta in Poor Performance Status in Non-small Cell Lung CancerCompletedNCT00508144Phase 2Results posted
• Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.TerminatedNCT00503971Phase 1/2Results posted
• Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung CancerCompletedNCT00499655Phase 2Results posted
• Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00499447Not applicableResults posted
• Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLCCompletedNCT00499109Phase 3Results posted
• Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495170Phase 2Results posted
• Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495040Phase 2Results posted
• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCCompletedNCT00492206Phase 2Results posted

← Carcinoma, Non-Small-Cell Lung overview